Kyprolis
Drug timelines are a Plus or Pro feature.
87 regulatory and trial events tracked for Kyprolis, covering 2012-07-20 to 2026-08-05. Get the full timeline:
Most recent: EMA Authorised: Kyprolis (carfilzomib) — Amgen Europe B.V.
87 regulatory and trial events tracked for Kyprolis, covering 2012-07-20 to 2026-08-05. Get the full timeline:
Most recent: EMA Authorised: Kyprolis (carfilzomib) — Amgen Europe B.V.